Patents by Inventor Anup BARDE

Anup BARDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
    Publication number: 20240181066
    Abstract: The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
    Type: Application
    Filed: September 22, 2023
    Publication date: June 6, 2024
    Inventors: David HUNG, Son Minh PHAM, Sarvajit CHAKRAVARTY, Jiyun CHEN, Jayakanth KANKANALA, Jeremy D. PETTIGREW, Anup BARDE, Anjan Kumar NAYAK
  • HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
    Publication number: 20210002293
    Abstract: Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
    Type: Application
    Filed: July 1, 2020
    Publication date: January 7, 2021
    Inventors: Son Minh PHAM, Sarvajit CHAKRAVARTY, Jayakanth KANKANALA, Jiyun CHEN, Chris P. MILLER, Jeremy D. PETTIGREW, Anjan Kumar NAYAK, Anup BARDE
  • HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
    Publication number: 20200140459
    Abstract: Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
    Type: Application
    Filed: October 30, 2019
    Publication date: May 7, 2020
    Inventors: Son Minh PHAM, Sarvajit CHAKRAVARTY, Jayakanth KANKANALA, Jiyun CHEN, Anjan Kumar NAYAK, Anup BARDE